Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
Ankylosing spondylitis (AS) is one of the major inflammatory diseases that affect the vertebral column and joints. The first-line drugs for the treatment of this disease are now nonsteroidal anti-inflammatory drugs (NSAIDs) that not only reduce painful sensations and rigidity, but also retard the ra...
Saved in:
| Main Author: | Yulia Leonidovna Korsakova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/437 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis
by: Rimma Mikhailovna Balabanova, et al.
Published: (2014-12-01) -
Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
by: A A Godzenko
Published: (2011-12-01) -
EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY
by: T. A. Raskina, et al.
Published: (2016-09-01) -
Treatment of ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2021-07-01) -
Problems of prescribing nonsteroidal anti-inflammatory drugs for reproductive-aged women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)